Organic compounds -- part of the class 532-570 series inventions 05/08

20080125591 - Blue-emitting organometallic complexes and their application: P

20080125592 - Process for preparing oxymorphone, naltrexone, and buprenorphine: Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included.... Agent: Greenblum & Bernstein, P.L.C

20080125593 - Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound: Imidazopyridine-based compounds and organic light emitting diodes (OLEDs) including organic layers including the imidazopyridine-based compounds are provided. The organic light emitting diodes including organic layers having the imidazopyridine-based compounds have low driving voltages, high efficiencies, high luminance, long life-times and low power consumption.... Agent: Christie, Parker & Hale, LLP

20080125594 - Process and intermediates for preparing integrase inhibitors: The invention provides synthetic processes and synthetic intermediates that can be used to prepare 4-oxoquinolone compounds having useful integrase inhibiting properties.... Agent: Viksnins Harris & Padys Pllp

20080125595 - Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, and processes of manufacturing the solutions: e

20080119653 - Method for the preparation of n-piperidino-1, 5-diphenylpyrazole-3-carboxamide derivatives: P

20080119654 - Amorphous form of esomeprazole salts: The invention relates to an amorphous form of the salts of the (-) enantiomer or (S)-enantiomer of omeprazole, i.e., esomeprazole. The invention also relates to processes for preparing amorphous esomeprazole salts and pharmaceutical compositions that include the amorphous esomeprazole salts.... Agent: Jayadeep R. Deshmukh, Esq. Ranbaxy Pharmaceuticals Inc.

20080114170 - Method for producing perylene-3,4-dicarboxylic acid imides: A process for preparing perylene-3,4-dicarboximides which bear a sterically demanding substituent on the imide nitrogen atom by reacting a perylene-3,4:9,10-tetracarboxylic dianhydride with a sterically hindered primary amine in a substantially anhydrous reaction medium, which comprises undertaking the reaction in the presence of a tertiary amine, of a solvent based on... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.c.

20080114171 - Solifenacin base forms and preparation thereof: Polymorphic forms of solifenacin base have been prepared and characterized. These polymorphic forms are particularly useful for preparing solifenacin salts.... Agent: Kenyon & Kenyon LLP

20080114172 - Synthesis of selected stereoisomers of certain substituted alcohols: A process for producing one selected stereoisomer of a substituted alcohol comprises reacting a stereoisomeric epoxide with an amine, a carboxylic acid, an amide, a sulfonyl, or a cyanide. The process avoids the production of a racemic mixture of stereoisomers of the prior art. Such a stereoisomeric substituted alcohol can... Agent: Bausch & Lomb Incorporated

20080114173 - Crystalline form of donepezil hydrochloride: A process for preparing crystalline form I of donepezil hydrochloride comprises: a) condensing 5,6-dimethoxy-2-piperidin-4-yl-methyl-indan-1-one with benzyl bromide and reacting a condensation product with hydrobromic acid to form donepezil hydrobromide; and b) hydrolyzing donepezil hydrobromide, followed by reacting with aqueous hydrochloric acid.... Agent: Dr. Reddy's Laboratories, Inc.

20080114174 - Ruthenium complexes with tridentate heterocyclic ligand and dye-sensitized solar cells using the same: in which R1, R2, R4 and R5 of L1 and L2 are the same or different substituents and represent alkyl, alkoxy, aminoalkyl, haloalkanes or substituted phenyl group, carboxylic acid group or acid radical salt thereof, sulfonic acid group or acid radical salt thereof, phosphoric acid group or acid radical salt... Agent: Jianq Chyun Intellectual Property Office

20080114175 - Processes and intermediates preparing cysteine protease inhibitors: The present invention is directed to a process for preparing certain cysteine protease inhibitors.... Agent: Berlex Biosciences, Corporate Patent Department

20080114176 - Process for the preparation of a 2-ethylaminopyridine derivative: e

20080108815 - Methods for preparing and using a zinc complex: wherein each R is the same or different from each other and each R represents H; an alkyl group having 1 to 16 carbon atoms; an acyl group, a carboxyalkyl group, an acylalkyl group, a carbamoylalkyl group, a cyanoalkyl group, a hydroxyalkyl group, an aminoalkyl group or a haloalkyl group,... Agent: Frishauf, Holtz, Goodman & Chick, Pc

20080108816 - Process for the preparation of (s)-4-fluoromethyl-dihydro-furan-2-one: e

20080108817 - Colorant compositions: Colorant compositions are useful for a wide variety of product applications. For example, colorants are used in tinting of polymers, providing colors to aqueous solution(s), and affording color to solid or semi-solid products such as detergents. Disclosed herein are colorant compositions having a triphenylmethane (“TPM”) structure having improved stability to... Agent: Legal Department (m-495)

20080108818 - Maleate, tosylate, fumarate and oxalate salts of 5-(1-(s)-amino-2-hydroxyethyl)-n-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore: Disclosed are maleate, tosylate, fumarate, and oxalate salts of the compound 5-(1(S)-Amino-2-Hydroxyethyl)-N-[(2,4-Difluorophenyl)-Methyl]-2-[8-Methoxy-2-(Trifluoromethyl)-5-Quinoline]-4-Oxazolecarboxamide, represented by Formula I, and methods of preparing the same.... Agent: Schering-plough Corporation Patent Department (k-6-1, 1990)

20080108819 - Novel indole derivatives and their use as medicament: The invention relates to novel indole derivatives of the general formula 1, to their preparation and to their use as medicaments, in particular for treating tumors.... Agent: Goodwin Procter L.l.p Attn: Patent Administrator

20080108820 - Hemiasterlin derivatives and uses thereof: The present invention provides compounds having formula (I): and additionally provides methods for the synthesis thereof and methods for the use thereof in the treatment of cancer, wherein R1-R7, X1, X2, R, Q, and n are as defined herein.... Agent: Choate, Hall & Stewart LLP

20080108821 - Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles: e

20080108822 - Regiospecific synthesis of nicotine derivatives: Methods of synthesizing nicotine analogs and derivatives are described. The methods are particularly useful for the regioselective production of enantiomerically pure nicotine analogs having substituents at the C4 position. Intermediates useful for the synthesis of such compounds are also described.... Agent: Myers Bigel Sibley & Sajovec

20080108823 - Method for producing thioether compound: Disclosed is an efficient and widely-applicable method for commercially producing a thioether compound or a thiol compound which is useful as a pharmaceutical compound or a production intermediate of it. Specifically disclosed is a method for producing a thioether compound represented by the general formula [I] below or a salt... Agent: Merck And Co., Inc

20080108824 - Medical devices incorporating a bioactive and methods of preparing such devices: One embodiment provides a medical device comprising a base material and a bioactive in contact with the base material, the bioactive having a proton binding site with a non-ionic form and an ionic form, the bioactive being less soluble in water when the proton binding site is in the non-ionic... Agent: Brinks Hofer Gilson & Lione/chicago/cook

20080108825 - Compounds for treatment of inflammation, diabetes and related disorders: Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal models of Type II diabetes mellitus. The compounds are... Agent: Jones Day

20080103308 - Organometallic complex and organic electroluminescent device using the same: Provided are a highly efficient phosphorescent organometallic complex and an organic electroluminescent (EL) device using the same. The organometallic complex can be used in the formation of an organic layer of the organic EL device, and can emit light in a red wavelength range as a highly efficient phosphorescent material.... Agent: Cantor Colburn, LLP

20080103309 - Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin: The invention discloses the preparation method of 7-ethyl-10-hydroxycamptothecin from 4-ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione and 1-(2-amino-5 -hydroxyphenyl)-propan-1-one using higher reaction temperature and faster heating to that temperature.... Agent: Birch Stewart Kolasch & Birch

20080103310 - Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo[4, 5-c]quinolin-4-phtalimide intermediates: The present invention provides process for the preparation of 4-amino-1H-imidazo[4,5-c]quinolines comprising the step of reacting a 1H-imidazo[4,5-c]quinolin-4-phthalimide with an amine selected from the group consisting of: alkylamine, aralkylamine, alkyldiamine, and aralkyldiamine.... Agent: Kenyon & Kenyon LLP

20080103311 - Retroviral protease inhibitors: N-heterocyclic moiety containing hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.... Agent: Banner & Witcoff, Ltd.